Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension).
AIM
The objective of the research is studying of demographic and clinical profile as well as treatment effectiveness of patients with AH and COPD based on National Register of Arterial Hypertension.


MATERIALS AND METHODS
Among the analyzed selection, consisted of 32 571 patients with AH, who were followed up in the primary medical care, at the average age of 64±7 years old (there were 64% women of them), 5.4% patients with AH had COPD. The analysis of cardiovascular and cerebrovascular diseases frequency as well as treatment effectiveness was made.


RESULTS
According to National Register of Arterial Hypertension, cardiovascular [coronary heart disease, Q myocardial infarction, chronic heart failure (CHF), peripheral artery atherosclerosis] and cerebrovascular (stroke/transitory ischemic attack) diseases are accurately more often diagnosed at patients with AH and COPD.


CONCLUSION
Male sex and age are the strongest independent factor, contributing into the risk of development of cardiovascular diseases at these patients. COPD considerably increases the risk of CHF development. The conducted analysis has shown that treatment, prescribed to patients with AH and COPD meets modern recommendations.
['Chazova|I E|IE|', 'Lazareva|N V|NV|', 'Oshchepkova|E V|EV|']
D000368:Aged D002318:Cardiovascular Diseases D002908:Chronic Disease D005260:Female D006333:Heart Failure D006801:Humans D006973:Hypertension D008297:Male D008875:Middle Aged D029424:Pulmonary Disease, Chronic Obstructive D012307:Risk Factors
arterial hypertension treatment effectiveness diagnosis national  register of arterial hypertension